Detalhe da pesquisa
1.
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial.
Oncologist
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38815151
2.
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.
Oncologist
; 2024 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38873934
3.
Criteria for the use of omics-based predictors in clinical trials.
Nature
; 502(7471): 317-20, 2013 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24132288
4.
A mutational comparison of adult and adolescent and young adult (AYA) colon cancer.
Cancer
; 124(5): 1070-1082, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29194591
5.
Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the future.
Cancer
; 122(7): 988-99, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26849003
6.
Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma.
Cancer
; 122(7): 1017-28, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26849082
7.
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2.
JCO Precis Oncol
; 8: e2300407, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603650
8.
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1.
JCO Precis Oncol
; 8: e2300406, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603651
9.
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J.
Clin Cancer Res
; 30(7): 1273-1280, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433347
10.
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E.
JCO Precis Oncol
; 8: e2300454, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38591867
11.
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.
BMC Med
; 11: 220, 2013 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24228635
12.
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH).
Clin Cancer Res
; 29(8): 1412-1422, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36662819
13.
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.
J Natl Cancer Inst
; 115(11): 1355-1363, 2023 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37228094
14.
The NCI-MATCH trial: lessons for precision oncology.
Nat Med
; 29(6): 1349-1357, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37322121
15.
Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial.
J Clin Oncol
; 40(20): 2235-2245, 2022 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363510
16.
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
J Clin Oncol
; 40(20): 2224-2234, 2022 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35353553
17.
The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.
J Natl Cancer Inst
; 113(1): 27-37, 2021 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32339229
18.
Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.
Cancer Cell
; 39(1): 38-53.e7, 2021 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33217343
19.
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design.
J Natl Cancer Inst
; 112(10): 1021-1029, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31922567
20.
Adolescent and Young Adult Cancer Biology.
Cancer J
; 24(6): 267-274, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30480571